Seeing Is Believing
Currently out of the existing stock ratings of Jeff Stent, 1 are a BUY (50%), 1 are a HOLD (50%).
Analyst Jeff Stent, currently employed at BNP, carries an average stock price target met ratio of 50% that have a potential upside of 31.65% achieved within 528 days.
Jeff Stent’s has documented 4 price targets and ratings displayed on 1 stocks. The coverage is on the Consumer Defensive sector.
Most recent stock forecast was given on KMB, Kimberly-Clark at 11-Jan-2022.
Analyst best performing recommendations are on KMB (KIMBERLY-CLARK).
The best stock recommendation documented was for KMB (KIMBERLY-CLARK) at 2/11/2019. The price target of $130 was fulfilled within 528 days with a profit of $31.25 (31.65%) receiving and performance score of 0.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$158
$25.33 (19.09%)
$161
17 days ago
(29-Jan-2025)
1/5 (20%)
$28.33 (21.85%)
291
Hold
$134
$1.33 (1.00%)
$132
17 days ago
(29-Jan-2025)
17/18 (94.44%)
$4.33 (3.34%)
287
Buy
$165
$32.33 (24.37%)
$165
22 days ago
(24-Jan-2025)
11/16 (68.75%)
$37.97 (29.89%)
297
Hold
$132
$-0.67 (-0.51%)
$144
29 days ago
(17-Jan-2025)
18/19 (94.74%)
$4.78 (3.76%)
126
Sell
$118
$-14.67 (-11.06%)
$125
30 days ago
(16-Jan-2025)
5/8 (62.5%)
$-8.03 (-6.37%)
60
What Year was the first public recommendation made by Jeff Stent?